Follow
Kateryna Fedorov, MD
Kateryna Fedorov, MD
Hematology Oncology Fellow, Montefiore Medical Center College of Medicine
Verified email at montefiore.org
Title
Cited by
Cited by
Year
Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave
M Lee, R Quinn, K Pradhan, K Fedorov, D Levitz, A Fromowitz, A Thakkar, ...
Cancer Cell 40 (4), 343-345, 2022
362022
Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions
K Fedorov, A Maiti, M Konopleva
Cancers 15 (8), 2312, 2023
92023
Direct oral anticoagulants for prevention of recurrent thrombosis in myeloproliferative neoplasms
K Fedorov, S Goel, M Kushnir, HH Billett
Blood 134, 4193, 2019
82019
Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
K Fedorov, S Goel, M Kushnir, HH Billett
Research and Practice in Thrombosis and Haemostasis 5 (6), e12574, 2021
72021
A metabolically optimized, noncytotoxic low-dose weekly decitabine/venetoclax in MDS and AML
D Levitz, Y Saunthararajah, K Fedorov, LC Shapiro, I Mantzaris, A Shastri, ...
Clinical Cancer Research 29 (15), 2774-2780, 2023
52023
Identifying neutrophil extracellular traps (NETs) in blood samples using peripheral smear autoanalyzers
K Fedorov, M Barouqa, D Yin, M Kushnir, HH Billett, M Reyes Gil
Life 13 (3), 623, 2023
32023
A non-cytotoxic regimen using a weekly low dose decitabine and venetoclax for MDS and AML in a real world cohort
D Levitz, K Fedorov, K Pradhan, LC Shapiro, A Shastri, K Gritsman, ...
Blood 140 (Supplement 1), 6218-6219, 2022
22022
Neutrophilic extracellular traps (NETs); A subset of smudge cells identifiable by peripheral smear autoanalyzers in the rising era of artificial intelligence
M Barouqa, K Ikemura, H Billett, M Kushnir, K Fedorov, D Yin, MR Gil
American Journal of Clinical Pathology 154 (Supplement_1), S10-S11, 2020
12020
Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population
L Laufer, L Amaeshi, A Sisto, K Fedorov, R Mathew, D Levitz, I Mantzaris, ...
Blood 142, 2350, 2023
2023
Comparison of the Prognostic Performance of European Leukemianet 2017 and 2022 Classifications in a Minority-Rich Population of Adult Patients with Acute Myeloid Leukemia
K Fedorov, A Sisto, J Kamel, M Forsberg, K Pradhan, N Shah, A Shastri, ...
Blood 142, 2968, 2023
2023
A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx
L Amaeshi, A Sisto, L Laufer, K Fedorov, R Mathew, D Levitz, I Mantzaris, ...
Blood 142, 7397, 2023
2023
P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7+ 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML
I Mantzaris, M Goldfinger, D Levitz, K Fedorov, A Munoz, N Chambers, ...
HemaSphere 7 (S3), e46119b8, 2023
2023
P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
K Fedorov, E Feldman, Y Saunthararajah, A Shastri, N Kornblum, A Sica, ...
HemaSphere 7 (S3), e90768e2, 2023
2023
Financial toxicity of hematologic malignancy therapies: Subjective experience of patients and impact on access to care.
K Fedorov, L Amaeshi, R Mathew, D Levitz, D Cole, A Sisto, K Singh, ...
Journal of Clinical Oncology 41 (16_suppl), e18907-e18907, 2023
2023
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS: Assessment of Leukemia Stem Cell Eradication By High-Resolution MRD Assay
I Mantzaris, M Goldfinger, D Levitz, K Fedorov, K Fehn, N Chambers, ...
Blood 140 (Supplement 1), 3360-3361, 2022
2022
Acute Clinical Syndrome of HLH in Patients with Hematologic Malignancy and EBV Infection
K Fedorov, D Levitz, A Fromowitz, I Murakhovskaya, A Verma
Blood 140 (Supplement 1), 13244-13245, 2022
2022
Autologous stem cell transplantation in an older adult population
K Fedorov, T Jain, K Pradhan, J Mustafa, A Lombardo, F Khatun, ...
Haematologica 107 (9), 2261, 2022
2022
LETTER TO THE EDITOR all economic backgrounds, but uninsured patients or those with Medicaid had significantly lower overall sur-vival. 19 Similar trends have been observed …
K Fedorov, T Jain, K Pradhan, J Mustafa, A Lombardo, F Khatun, ...
Haematologica 107, 2022
2022
Safety of Autologous Hematopoietic Stem Cell Transplantation in Patients over 75 Years Old. Single Center Experience Serving a Minority Population
K Fedorov, T Jain, J Mustafa, A Lombardo, F Khatun, F Joseph, K Gillick, ...
Blood 138 (Supplement 1), 1833-1833, 2021
2021
Neutrophil Extracellular Traps (NETs) Are a Subset of Smudge Cells Identifiable By Peripheral Smear Autoanalyzers
HH Billett, K Fedorov, M Kushnir, D Yin, MR Gil
Blood 134, 2321, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20